Log In
Print
BCIQ
Print
Print this Print this
 

Ampligen, rintatolimod

  Manage Alerts
Collapse Summary General Information
Company Hemispherx Biopharma Inc.
DescriptionDouble-stranded RNA antiviral agent that agonizes toll-like receptor 3 (TLR3)
Molecular Target 2',5'-oligoadenylate synthetase 1, 40-46kDa (OAS1) ; Toll-like receptor 3 (TLR3)
Mechanism of ActionImmune modulation; Toll-like receptor 3 (TLR3) agonist
Therapeutic ModalityNucleic acid

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

3

$1.0M

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone
Get a free BioCentury trial today